Welcome to our dedicated page for Enovix SEC filings (Ticker: ENVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Enovix's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Enovix's regulatory disclosures and financial reporting.
Enovix Corporation (ENVX) Chief Operating Officer Ajay Marathe reported equity award activity in company stock. On November 21, 2025, he received 6,035 shares of common stock at $0, issued upon the vesting of restricted stock units that represented his bonus for the quarter ended September 28, 2025.
On the same date, 3,190 shares were withheld at a price of $7.47 to cover tax obligations tied to the RSU vesting. After these transactions, Marathe beneficially owned 989,363 shares of Enovix common stock, including large amounts issuable from previously granted RSUs and vested performance RSUs scheduled for release in 2026 and 2027.
Enovix Corp (ENVX) reported a routine insider equity transaction by its Chief Financial Officer. On November 21, 2025, the reporting person received 5,729 shares of common stock through a fully vested restricted stock unit (RSU) award that served as a bonus for the quarter ended September 28, 2025, at a stated price of $0 per share. On the same date, 3,028 shares of common stock were withheld at $7.47 per share to cover tax obligations related to this RSU vesting. After these transactions, the reporting person beneficially owned 753,690 shares of Enovix common stock, including 748,752 shares issuable upon settlement of previously granted RSUs.
Enovix Corporation (ENVX) reported insider equity activity by its President and CEO, who is also a director. On November 21, 2025, the executive received 9,427 shares of common stock at $0, issued upon the vesting of restricted stock units (RSUs) that represent bonus awards for the quarter ended September 28, 2025. On the same date, 4,983 shares were withheld at a price of $7.47 to cover tax obligations tied to this RSU vesting.
Following these transactions, the executive beneficially owned 2,298,829 shares of Enovix common stock on a direct basis. This total includes 1,674,293 shares underlying RSUs and 95,551 vested performance RSUs (PRSUs), with half of the PRSUs scheduled for release on March 2, 2026 and the remainder on March 1, 2027. Each RSU or PRSU represents the right to receive one share of common stock.
Enovix Corporation (ENVX) reported an insider stock transaction by its President, CEO and Director, Raj Talluri. On November 20, 2025, he donated 925 shares of Enovix common stock to two charitable organizations at a reported price of $0, reflecting a gift rather than a sale. After this donation, he beneficially owned 2,294,385 shares of Enovix common stock. This total includes 1,674,293 shares issuable upon settlement of restricted stock units (RSUs) and 95,551 vested performance RSUs. For the performance RSUs, 50% are scheduled to be released on March 2, 2026 and the remaining 50% on March 1, 2027, with each PRSU representing the right to receive one share upon settlement.
Enovix Corporation (ENVX) president and CEO Raj Talluri, who also serves as a director, reported an automatic share withholding related to equity compensation. On November 18, 2025, 17,617 shares of Enovix common stock were withheld at a price of $7.50 per share to cover tax obligations triggered by the vesting of restricted stock units (RSUs). These are not open-market sales but shares retained by the company for taxes.
Following this transaction, Talluri beneficially owns 2,295,310 Enovix shares in total. This amount includes 1,674,293 shares issuable upon settlement of RSUs and 95,551 shares of vested performance RSUs (PRSUs), with half of the PRSUs scheduled to be released on March 2, 2026 and the remaining half on March 1, 2027. Each RSU and PRSU represents a right to receive one share of Enovix common stock.
Enovix Corporation’s Chief Operating Officer, Ajay Marathe, reported an automatic share withholding related to equity compensation. On November 14, 2025, 7,338 shares of Enovix common stock were withheld at $8.03 per share to cover tax obligations arising from the vesting of restricted stock units (RSUs). After this transaction, Marathe beneficially owned 986,518 shares, including 743,818 shares tied to unvested RSUs and 33,170 vested performance RSUs (PRSUs). Half of these PRSUs are scheduled for release on March 2, 2026, with the remaining half on March 1, 2027, each representing a right to receive one share upon settlement.
Enovix Corp (ENVX) reported an insider equity transaction by its Chief Accounting Officer, Kristina Truong. On November 13, 2025, 1,013 shares of common stock were withheld at a price of $8.08 to cover tax obligations related to the vesting of restricted stock units (RSUs). After this transaction, the reporting person beneficially owned 198,502 shares of common stock.
This total includes 155,474 shares issuable upon vesting and settlement of RSUs and 4,978 vested performance RSUs (PRSUs). For these PRSUs, 50% of the shares are scheduled to be released on March 2, 2026 and the remaining 50% on March 1, 2027, with each RSU or PRSU representing the right to receive one share of Enovix common stock.
Enovix (ENVX) reported an insider Form 4 for its Chief Accounting Officer. On November 10, 2025, 252 shares of common stock were withheld at $9.28 to satisfy taxes upon RSU vesting (code F, a non‑open‑market transaction). Following this, the officer beneficially owned 199,515 shares.
This ownership includes 157,389 shares issuable upon RSU settlement and 4,978 vested PRSUs, with 50% scheduled for release on March 2, 2026 and the remaining 50% on March 1, 2027. It also reflects 2,033 shares acquired under the 2021 ESPP on November 7, 2025.
Enovix (ENVX) reported a Form 4 for COO Ajay Marathe. On 11/08/2025, 1,490 shares were withheld (Code F) to cover taxes upon RSU vesting at $9.56 per share.
After the transaction, beneficial ownership stands at 993,856 shares. This includes 757,702 shares issuable from RSUs and 33,170 vested PRSUs, with 50% scheduled for release on March 2, 2026 and the remaining 50% on March 1, 2027.
Enovix (ENVX) reported an insider transaction by its Chief Legal Officer on a Form 4. On November 8, 2025, 934 shares of common stock were withheld at $9.56 to cover taxes upon the vesting of restricted stock units (Transaction Code F). Following the transaction, the reporting person directly beneficially owned 424,035 shares.
Holdings include 307,469 shares issuable upon the settlement of RSUs and 20,786 vested PRSUs, with 50% scheduled to be released on March 2, 2026 and the remaining 50% on March 1, 2027.